Who are CHG antiseptic body cleanser's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Silvadene, chlorhexidine digluconate, Colistin/Polymyxin B + Tigecycline/Eravacycline, Chlorhexidine 0.06% mouthrinse, PerioChip ®, Polysporin Ointment.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/chg-antiseptic-body-cleanser.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

CHG antiseptic body cleanser — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CHG antiseptic body cleanser (CHG antiseptic body cleanser) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimicrobial antiseptic. Area: Infection Prevention / Dermatology.

marketed Antimicrobial antiseptic Bacterial cell membrane Infection Prevention / Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

CHG antiseptic body cleanser (CHG antiseptic body cleanser) — Baycrest. CHG (chlorhexidine gluconate) is an antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, providing broad-spectrum antiseptic activity.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
CHG antiseptic body cleanser TARGET	CHG antiseptic body cleanser	Baycrest	marketed	Antimicrobial antiseptic	Bacterial cell membrane
Silvadene	Silver Sulfadiazine	Pfizer	marketed	sulfonamide antimicrobial	bacterial cell membrane and cell wall	1973-01-01
chlorhexidine digluconate	chlorhexidine digluconate	Universidade Federal do Ceara	marketed	Antimicrobial agent / Antiseptic	Bacterial cell membrane and proteins
Colistin/Polymyxin B + Tigecycline/Eravacycline	Colistin/Polymyxin B + Tigecycline/Eravacycline	National University of Singapore	marketed	Polymyxin + tetracycline combination antibiotic	Bacterial cell membrane (polymyxins) and 30S ribosome (tetracyclines)
Chlorhexidine 0.06% mouthrinse	Chlorhexidine 0.06% mouthrinse	University of Oslo	marketed	Antimicrobial oral rinse	Bacterial cell membrane and proteins
PerioChip ®	PerioChip ®	Dexcel Pharma Technologies Ltd.	marketed	Local antimicrobial agent	Bacterial cell membranes (chlorhexidine non-specific antimicrobial)
Polysporin Ointment	Polysporin Ointment	University of British Columbia	marketed	Topical antibiotic combination	Bacterial cell wall (bacitracin) and bacterial cell membrane (polymyxin B)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimicrobial antiseptic class)

B. Braun Ltd. Centre of Excellence Infection Control · 1 drug in this class
Baycrest · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). CHG antiseptic body cleanser — Competitive Intelligence Brief. https://druglandscape.com/ci/chg-antiseptic-body-cleanser. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab